EL vs RNAZ · rev $15.05B vs $5.1M cap
Estee Lauder Companies Inc (EL) versus Transcode Therapeutics Inc (RNAZ) — a side-by-side from cached financials, not a winner call.
Estee Lauder Companies Inc (EL) is a household & personal products company listed on US.
Transcode Therapeutics Inc (RNAZ) is a biotechnology company listed on NASDAQ.
Latest reported EL revenue for 2026-06-30 was $15.05B. Net income was $182.0M. Revenue was up 5.0% from 2025-06-30 to 2026-06-30. EL currently screens at market cap $31.92B.
RNAZ does not have a complete income-statement cache yet.
EL currently screens at market cap $31.92B. RNAZ currently screens at market cap $5.1M.
Not investment advice. Open the EL and RNAZ stock pages for the full models.
Not investment advice.